Pre-Orders Now Open for Nanovial Multicell Assay Kits
Partillion Bioscience Corporation, a forward-thinking life science tools company, has announced the launch of pre-orders for its cutting-edge Nanovial Multicell Assay Kits. This innovative platform allows researchers to investigate cell-to-cell interactions in an entirely new way, making significant inroads in antibody discovery and therapeutic development.
The Breakthrough of Nanovial Technology
The Nanovial Multicell Assay utilizes larger EZM™ Nanovials, which allows for the simultaneous loading of target and antibody-secreting cells. This entails an enormous leap in the ability to screen large populations of antibody-secreting cells based on their binding efficiencies to target cells. The potential for therapeutic advancements is immense, and this revolutionary platform is a continuation of Partillion's previous successes, including past accolades for its Nanovial technology.
Revolutionizing Cell-Based Assays
What sets these kits apart is their potential to replace traditional microwell plate-based assays. When employing the Nanovial Multicell Assay, researchers can conduct assays that would normally require thousands of microwell plates within just a single microcentrifuge tube. This advancement allows for efficient co-loading of cell pairs like antigen-expressing cells alongside plasma B cells, all preserved in nanoliter-scale hydrogel compartments. This unique aspect of the technology elevates the relevance of findings, ensuring that the cell interactions observed are authentic and biologically significant.
Features and Benefits of the Kits
The Nanovial Multicell Antibody Discovery Kits come with ready-to-use reagents and feature validated capture antibodies for prevalent cell types including mouse plasma B cells and human leukocytes. As the exploration of cellular interactions becomes increasingly critical, Partillion is committed to expanding their format offerings for various additional cell pairs, enhancing the versatility and application scope of their technology.
Insightful Demonstrations at SLAS 2025
At the forefront of cellular research innovation, Partillion's Nanovial technology will be a focal point of discussion at SLAS 2025. Two talks will be presented, illustrating the profound effects of Nanovials on both single-cell and multicell analysis. Notably, one presentation will delve into how this technology facilitates the detection of heterogeneous secretion patterns, connecting intricate cellular dynamics in real-time.
Practical Applications of the Discovery Kits
These kits have gained traction among early access users and academic partners, who leverage this unique technology to derive valuable insights into immune responses, especially in the context of cancer. With the ability to map cellular communication more accurately, researchers can fine-tune cell therapies and potentially revolutionize treatment strategies. The capabilities illustrated by early adopters showcase the promising landscape expanding from their antibody discovery processes.
Get Involved with Partillion at SLAS 2025
Attendees of SLAS 2025 are encouraged to join Partillion at Booth 2853 to experience how Nanovials are set to redefine the methodologies associated with cell-based assays. The advancements promised by the Nanovial Multicell Assays are reshaping how scientific research is executed, offering a pragmatic solution to one of the biggest challenges in the field of life sciences.
About Partillion Bioscience
Partillion Bioscience operates with a mission to enhance therapeutic development through its groundbreaking single-cell analysis platform. The company's Nanovial technology empowers researchers to screen a vast number of individual cells effectively, addressing some of the more complex challenges faced in cell biology today. With an impressive history of recognition, including a number of prestigious awards for innovation, Partillion continues to make strides in the life sciences arena. This advancement ensures that scientists can effectively access critical functional information and utilize readily available lab equipment, bridging a significant gap within the scientific community and enhancing research efficiency.
Frequently Asked Questions
What are the Nanovial Multicell Assay Kits?
The Nanovial Multicell Assay Kits are innovative tools developed by Partillion Bioscience for studying cell-to-cell interactions and enhancing antibody discovery processes.
How do these kits improve traditional assay methods?
These kits allow for the co-loading of cell pairs which enables high-throughput screening in a significantly smaller space compared to traditional microwell plates, increasing efficiency.
What is the significance of the Nanovial technology?
The Nanovial technology is recognized for its ability to maintain and facilitate meaningful cellular interactions, leading to more biologically relevant research outcomes.
Where can I learn more about these products?
To get comprehensive insights and details about the Nanovial Multicell Assay Kits, refer to Partillion Bioscience's official website, where you can find product information and pre-order options.
Will Partillion be presenting at any conferences?
Yes, Partillion will present its Nanovial technology at SLAS 2025, showcasing its applications and impact on cellular research.
